ArticleNature2024
Cephalopod-inspired jetting devices for gastrointestinal drug delivery.
Abstract read
In one paragraph
Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Dynamic coupling enables impulsive ejection in a hydrogel catapult.Nature communications · 2026Article
- Assembly delivery of bioactive matters: Advances, challenges, and prospects.Journal of advanced research · 2026Review
- Review of Gastrointestinal Capsule Robots: Materials, Actuation, Diagnostics, and Therapeutics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Toward autonomous robotic-assisted and microrobotic surgery.Science advances · 2026Review
- Liquid Metals for Reconfigurable Bioelectronics.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Oral capsule administration of biomacromolecules that achieves bioavailability and pharmacokinetics comparable to subcutaneous injection in dogs - the BIONDDDrug delivery and translational research · 2026Article
- Microrobotic copper-rich electrochemical interfacing for targeted cancer theranostics in the gut.Science advances · 2026Article
- Dynamic and living devices for overcoming fibrosis of implanted biomaterials.Bioengineering & translational medicine · 2026Review
- Review
- Physical Intelligence in Small-Scale Robots and Machines.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- A magnetically actuated robotic capsule endoscope for in-situ visualization and microneedle-mediated targeted drug delivery in gastrointestinal tract.Microsystems & nanoengineering · 2026Article
- Oral delivery of biologics: from barrier-limited formulation to active convective transport.Frontiers in drug delivery · 2026Review
- Building the next frontier: Artificial intelligence in 3D-printed medicines.Biomaterials translational · 2026Review
- Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage.Frontiers in drug delivery · 2026Review
- A Pill That Prints-An Ingestible Bioprinter for Non-Invasive Structured Bioink Deposition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Stable magnetic soft structures.Science advances · 2025Article
- A gastric retentive robotic capsule enables emergency-prepared and responsive oral drug delivery in canine models.Science advances · 2025Article
- Gastrointestinal delivery of mRNA lipid nanoparticles selectively targets the pancreas.bioRxiv : the preprint server for biology · 2025Article
- Autonomous devices for drug delivery.Nature biomedical engineering · 2025Article
- Capsule Technologies for Disorders of Gut-Brain Interaction: Hope or Hype?Gastroenterology & hepatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
42 authors.
G Arrick *Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
D Sticker *Global Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
A Ghazal *Global Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
Y LuDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
T DuncombeGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
D GwynneDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
B MouridsenGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
J WainerDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-4845-228X
J P H JepsenGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
T S LastDivision of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
D SchultzGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
K HessDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0003-2837-0305
E Medina De AlbaGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.ORCID 0009-0005-6579-6307
S MinDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-7308-6840
M PoulsenGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
C AnkerGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
P KarandikarDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-3529-2037
H D PedersenGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
J CollinsDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
N E EgeciogluGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
S TamangDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
C ClevelandGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
K IshidaDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
A H UhrenfeldtGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
J KuosmanenDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
M PereverzinaGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
A HaywardDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
R K KirkGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
S YouDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
C M DalsgaardGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
S B GunnarssonGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
I PatsiGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
A BohrGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
A AzzarelloGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
M R FrederiksenGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
P HerskindGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
J LiDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
N RoxhedMicro and Nanosystems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0002-7147-6730
U L RahbekGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.ORCID 0000-0002-1255-0232
J J WaterGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark.
S T BuckleyGlobal Research Technologies, Device and Delivery Solutions, Global Drug Discovery and Clinical Drug Development, Novo Nordisk A/S, Bagsværd, Denmark. spby@novonordisk.com.
G TraversoDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.ORCID 0000-0001-7851-4077
Funding
Natural Sciences and Engineering Research Council of CanadaNovo Nordisk A/S
Abstract
Needle-based injections currently enable the administration of a wide range of biomacromolecule therapies across the body, including the gastrointestinal tract
Indexed as
Drug Delivery SystemsEquipment DesignGastrointestinal TractInjections, JetAnimalsCephalopodaDogsFemaleGlucagon-Like Peptide 1InsulinMalePressureRNA, Small InterferingSwineGlucagon-Like Peptide 1InsulinRNA, Small Interfering
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.